Uneingeschränkter Zugang

Antimicrobial Resistance and Biofilm Formation of Staphylococcus aureus Isolates from Febrile Cases: Findings from a Rural Cohort of Odisha, India


Zitieren

Fig. 1.

A) Schematic presentation of methodology adopted for the study; B) figure represents the percentage of Staphylococcus aureus isolates showing resistance to multiple antibiotics. They were divided into four groups: resistant to two antibiotics, resistant to three to five antibiotics, resistant to six to nine antibiotics, and resistant to more than nine antibiotics; C) figure represents the percentage of S. aureus isolates showing biofilm forming ability as weak, moderate and strong biofilm producers.
A) Schematic presentation of methodology adopted for the study; B) figure represents the percentage of Staphylococcus aureus isolates showing resistance to multiple antibiotics. They were divided into four groups: resistant to two antibiotics, resistant to three to five antibiotics, resistant to six to nine antibiotics, and resistant to more than nine antibiotics; C) figure represents the percentage of S. aureus isolates showing biofilm forming ability as weak, moderate and strong biofilm producers.

Antibiotic susceptibility pattern of Staphylococcus aureus (n = 73).

Name of antibiotics S I R
Penicillin   8 (11%)   0 (0%) 65 (89%)
Ampicillin   9 (12%)   0 (0%) 64 (88%)
Erythromycin   9 (12%)   7 (10%) 57 (78%)
Azithromycin 18 (25%)   3 (4%) 52 (71%)
Cefoxitin 33 (45%)   0 (0%) 40 (55%)
Co-trimoxazole 35 (48%)   2 (3%) 36 (49%)
Clindamycin 52 (71%) 11 (15%) 10 (14%)
Teicoplanin 54 (74%)   8 (11%) 11 (15%)
Ciprofloxacin 59 (81%)   2 (3%) 12 (16%)
Vancomycin 58 (81%) 10 (12%)   5 (7%)
Chloramphenicol 62 (85%)   5 (7%)   6 (8%)
Levofloxacin 62 (85%)   5 (7%)   6 (8%)
Tetracycline 67 (92%)   0 (0%)   6 (8%)
Gentamicin 71 (97%)   0 (0%)   2 (3%)
Linezolid 73 (100%)   0 (0%)   0 (0%)

Details of antibiotic susceptibility pattern of strong biofilm-forming Staphylococcus aureus.

Sample ID Antibiotic
  38 COT, VA, C, TEI, LZ, CD, TE
116 GEN, COT, CIP, C, LZ, TE, LE
143 GEN, COT, CIP, VA, C, LZ, TE, LE
153 GEN, COT, CIP, VA, C, CX, LZ, CD, TE, LE
156 GEN, COT, CIP, VA, C, TEI, CX, LZ, CD, TE, LE
161 GEN, COT, AMP, CIP, AZM, VA, C, TEI, P, CX, E, LZ, CD, TE, LE
221 GEN, CIP, C, TEI, LZ, CD, TE, LE
229 GEN, CIP, VA, C, TEI, LZ, CD, TE, LE
231 GEN, CIP, VA, C, TEI, CX, LZ, CD, TE, LE
236 GEN, CIP, VA, C, TEI, LZ, CD, TE, LE
241 GEN, COT, AMP, CIP, AZM, VA, C, TEI, LZ, TE, LE
242 GEN, CIP, VA, C, TEI, CX, LZ, CD, TE, LE
271 GEN, CIP, AZM, VA, C, TEI, LZ, CD, LE
277 GEN, CIP, C, LZ, CD, TE, LE
350 GEN, COT, CIP, VA, LZ, TE, LE
352 GEN, VA, TEI, LZ, TE
354 GEN, COT, CIP, AZM, VA, TEI, E, LZ, CD, TE, LE
382 GEN, CIP, VA, C, TEI, CX, LZ, CD, TE, LE
498 GEN, COT, CIP, VA, C, TEI, CX, LZ, CD, TE, LE
515 GEN, AMP, CIP, VA, C, TEI, P, CX, LZ, CD, TE, LE
eISSN:
2544-4646
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Biologie, Mikrobiologie und Virologie